Who owns Glycomimetics?

Tip: Access positions for across all investors

Analyze quarterly positions in Glycomimetics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Glycomimetics stock

Who bought or sold Glycomimetics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 9.5M $23M 0% Dec 2023
 View chart
Artal Group 8.6M $20M 0% Dec 2023
 View chart
NEA Management Company 4.8M $11M 0% Dec 2023
 View chart
Octagon Capital Advisors 3.0M $7.1M 0% Dec 2023
 View chart
Vanguard Group 2.4M $5.7M 0% Dec 2023
 View chart
Axa 1.6M $2.4M 0% Sep 2023
 View chart
Goldman Sachs Group 919k $2.2M 16% Dec 2023
 View chart
Acadian Asset Management 844k $1.3M -27% Sep 2023
 View chart
BlackRock 735k $1.1M -6% Sep 2023
 View chart
Geode Capital Management 460k $690k -3% Sep 2023
 View chart
Susquehanna International 252k $378k 34% Sep 2023
 View chart
Renaissance Technologies 201k $302k 73% Sep 2023
 View chart
GSA Capital Partners 201k $474k 114% Dec 2023
 View chart
State Street Corporation 187k $280k 0% Sep 2023
 View chart
Bridgeway Capital Management 172k $258k 27% Sep 2023
 View chart
Two Sigma Advisers 165k $390k -24% Dec 2023
 View chart
Connor, Clark & Lunn Investment Management 143k $338k -4% Dec 2023
 View chart
Northern Trust 106k $159k -12% Sep 2023
 View chart
Mjp Associates 101k $238k 100% Dec 2023
 View chart
Advisor OS 101k $238k 100% Dec 2023
 View chart
Franklin Resources 96k $226k 0% Dec 2023
 View chart
Simplex Trading 72k $170k 100% Dec 2023
 View chart
Two Sigma Investments 60k $141k -48% Dec 2023
 View chart
Sargent Investment Group 58k $137k 0% Dec 2023
 View chart
Jane Street 57k $135k 186% Dec 2023
 View chart
Intellectus Partners 51k $120k -18% Dec 2023
 View chart
Letko, Brosseau & Associates 45k $107k 0% Dec 2023
 View chart
Morgan Stanley 40k $61k -59% Sep 2023
 View chart
Millennium Management 39k $92k -39% Dec 2023
 View chart
Ieq Capital 38k $91k 0% Dec 2023
 View chart
Virtu Financial 34k $81k 100% Dec 2023
 View chart
XTX Topco 33k $49k 9% Sep 2023
 View chart
Group One Trading 28k $43k -48% Sep 2023
 View chart
Longwood Capital Partners 28k $41k 100% Sep 2023
 View chart
Bank of New York Mellon 25k $58k -1% Dec 2023
 View chart
Citadel Advisors 24k $58k 100% Dec 2023
 View chart
Charles Schwab Investment Management 22k $53k 0% Dec 2023
 View chart
Citigroup 22k $51k 100% Dec 2023
 View chart
Bank of America Corporation 20k $47k 143% Dec 2023
 View chart
683 Capital Management 19k $46k 100% Dec 2023
 View chart
Tobias Financial Advisors 15k $23k 0% Sep 2023
 View chart
LPL Financial 13k $20k 30% Sep 2023
 View chart
Marshall Wace 13k $30k 100% Dec 2023
 View chart
Pine Valley Investments Ltd Liability 13k $30k 0% Dec 2023
 View chart
Tower Research Capital 4.7k $7.0k -46% Sep 2023
 View chart
Hartford Financial Management 3.5k $8.3k 0% Dec 2023
 View chart
Truvestments Capital 2.1k $3.1k 0% Sep 2023
 View chart
Jpmorgan Chase & Co 1.6k $3.8k 246% Dec 2023
 View chart
Rhumbline Advisers 1.0k $2.5k 0% Dec 2023
 View chart
UBS Group 683.00 $1.6k 100% Dec 2023
 View chart
ORG Partners 500.00 $1.2k 100% Dec 2023
 View chart
Bnp Paribas Arbitrage, Snc 481.00 $1.1k 0% Dec 2023
 View chart
Qube Research & Technologies 399.00 $599.018700 100% Sep 2023
 View chart
Wells Fargo & Company 377.00 $889.983900 6% Dec 2023
 View chart
Barclays 76.00 $0 -50% Dec 2023
 View chart

Who sold out of Glycomimetics?

Fund or Company Name Date Sold Shares Held Valued At
Dimensional Fund Advisors Sep 2023 45k $67k
Chicago Partners Investment Sep 2023 20k $23k
Commonwealth Equity Services Sep 2023 10k $15k
Creative Planning Sep 2023 10k $15k
Carolinas Wealth Consulting Jun 2023 395.00 $686.984000
Signature Sep 2023 100.00 $150.000000